<DOC>
	<DOC>NCT01664117</DOC>
	<brief_summary>This observational multicenter study will evaluate the management of disease and safety in clinical practice in patients with moderate to severe rheumatoid arthritis receiving any biological therapies in monotherapy.</brief_summary>
	<brief_title>An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Adult patients, &gt;/=18 years of age Patients with moderate to severe rheumatoid arthritis who have had an inadequate response or intolerance to disease modifying antirheumatic drugs (DMARDs) or other biological drugs Patients treated with biologic DMARDs alone for at least 6 months Patients not willing or unable to give written informed consent for participation in this study Patients who are participating in any clinical trial at the time of this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>